Working… Menu

A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBCL Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02772822
Recruitment Status : Unknown
Verified May 2016 by Sinocelltech Ltd..
Recruitment status was:  Not yet recruiting
First Posted : May 16, 2016
Last Update Posted : May 16, 2016
Information provided by (Responsible Party):
Sinocelltech Ltd.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : December 2019